Sea Grape

Sea grape contains three primary anthocyanins—cyanidin-3-glucoside, malvidin-3-glucoside, and delphinidin-3-glucoside—alongside phenolic acids including gallic, ferulic, and chlorogenic acid, which neutralize reactive oxygen species via hydrogen atom donation from hydroxyl groups. In vitro assays measured a total phenol content of 263.86 ± 1.86 mg gallic acid equivalent per 100 g and antioxidant capacity of 128.95 ± 1.00 µg Trolox equivalents/mL by ABTS, with crude berry extracts demonstrating significant anti-inflammatory and antioxidant activity at 250 µg/mL.

Origin & History

Coccoloba uvifera is a flowering tree native to coastal regions of the Caribbean, Florida, Central America, and northern South America, thriving in sandy, saline soils along shorelines and in tropical coastal scrub environments. It is well-adapted to salt spray, high temperatures, and periodic drought, making it a dominant species in littoral zones across the Atlantic and Pacific island territories. The plant has been cultivated informally for its edible berries and landscape value throughout the Caribbean basin for centuries.

Historical & Cultural Context

Coccoloba uvifera has been a culturally significant plant throughout the Caribbean and coastal Central America for centuries, valued by indigenous peoples and later by colonial-era settlers for its edible grape-like berries, which were used to make jelly, wine, and beverages. In traditional medicine systems across the Caribbean islands, the Pacific coastal territories, and parts of Florida, the leaves were commonly prepared as a decoction to treat diarrhea, dysentery, and gastrointestinal complaints, representing one of the most consistent ethnomedical applications of the plant. Anecdotal reports also describe use of the berries and bark for managing high blood pressure and asthma symptoms, suggesting broader therapeutic attribution by local healers beyond its primary gastrointestinal indication. The plant holds ecological and cultural importance as a coastal stabilizer, shade tree, and wildlife forage species, and its culinary use—particularly the production of sea grape jelly—remains a regional tradition in the Bahamas, Puerto Rico, and the US Virgin Islands.

Health Benefits

- **Antioxidant Activity**: Sea grape extract provides a total phenol content of 263.86 ± 1.86 mg GAE/100 g, comparable to kiwi and orange, with an ABTS antioxidant capacity of 128.95 ± 1.00 µg Trolox equivalents/mL, attributed to anthocyanins and phenolic acids donating hydrogen atoms to neutralize free radicals.
- **Anti-inflammatory Effects**: Crude berry extracts demonstrated significant anti-inflammatory activity in vitro at 250 µg/mL, with the mechanism linked to phenolic compounds modulating inflammatory mediators and potentially reducing oxidative stress-driven inflammation.
- **Traditional Antidiarrheal Use**: The leaves have a long history of use in Caribbean and Pacific coastal communities as a remedy for diarrhea, likely due to the astringent tannin and phenolic content of leaf tissue that may reduce intestinal motility and fluid secretion.
- **Potential Neuroprotective Support**: The anti-inflammatory and antioxidant properties of sea grape anthocyanins are hypothesized to reduce oxidative stress-driven neurodegenerative processes, with researchers suggesting possible relevance to conditions such as Parkinson's disease, though direct clinical evidence is absent.
- **Cardiovascular and Metabolic Disease Risk Reduction**: Polyphenols, flavonoids, and carotenoids present in sea grape are associated in epidemiological frameworks with reduced risk of cardiovascular disease, diabetes, and certain cancers, operating through inhibition of lipid peroxidation and modulation of inflammatory pathways.
- **Anecdotal Antihypertensive Properties**: Ethnobotanical reports from Florida and Caribbean populations describe sea grape berries as having antihypertensive effects, possibly linked to the vasodilatory or ACE-inhibitory potential of flavonoid fractions, though no controlled human trials have validated this claim.
- **Antimutagenicity**: Spray-dried microencapsulated sea grape extract was found to maintain antimutagenicity activity comparable to fresh extract, suggesting that bioactive compounds responsible for DNA-protective effects survive processing, potentially useful in food-based cancer prevention strategies.

How It Works

The primary mechanism of action for sea grape's bioactive compounds involves electron transfer: anthocyanins (cyanidin-3-glucoside, malvidin-3-glucoside, and delphinidin-3-glucoside) and phenolic acids (gallic, ferulic, and chlorogenic acid) donate hydrogen atoms from their phenolic hydroxyl groups to reactive oxygen species, effectively quenching free radicals and halting oxidative chain reactions. This antioxidant capacity, confirmed to correlate significantly with total phenol content (p < 0.05), operates through both hydrophilic and hydrophobic pathways as evidenced by the differential results between ABTS and DPPH assays—the ABTS method capturing a broader spectrum of antioxidant capacity (128.95 µg TE/mL) than the DPPH method restricted to polar compounds (26.18 µg TE/mL). Anti-inflammatory activity is attributed to phenolic compounds modulating the production of pro-inflammatory cytokines and reducing NF-κB pathway activation, though specific receptor-level targets have not been fully characterized in published literature for this species. The tannin and phenolic content of the leaves likely contributes to the traditional antidiarrheal effect by precipitating mucosal proteins, reducing intestinal secretion, and exerting an astringent action on gut epithelium.

Scientific Research

The current evidence base for Coccoloba uvifera is limited almost entirely to in vitro phytochemical characterization and extraction optimization studies, with no published randomized controlled trials or large observational cohort studies in humans identified in the available literature. One in vitro study quantified antioxidant capacity using ABTS and DPPH assays and characterized three major anthocyanins alongside phenolic acids, providing foundational phytochemical data but no clinical efficacy outcomes. A separate microencapsulation study using spray drying with maltodextrin demonstrated that bioactive compounds, including antimutagenic activity, could be preserved in a powder form with 76 ± 3.60% solubility and a mean particle size of 6.28 µm, representing a technology development study rather than a therapeutic trial. Ethnobotanical reports support traditional use for diarrhea and anecdotal antihypertensive and anti-asthmatic claims, but these have not been validated in controlled human studies, placing the overall evidence firmly in the preliminary, preclinical category.

Clinical Summary

No formal clinical trials evaluating the therapeutic efficacy of Coccoloba uvifera in human subjects have been identified in the published literature. The available research consists of in vitro antioxidant and anti-inflammatory assays, phytochemical profiling, and food technology studies focused on microencapsulation and extract stabilization rather than clinical endpoints. Ethnobotanical documentation from Caribbean and Pacific island communities records use of leaves for diarrhea and berries for hypertension and asthma, but effect sizes, dosing parameters, and safety margins from human studies remain unestablished. Confidence in therapeutic recommendations based on current data is low, and controlled clinical investigation is needed before any evidence-based dosing guidance can be issued.

Nutritional Profile

Sea grape berries contain polyphenols, flavonoids, and carotenoids as primary phytochemical constituents, with total phenol content measured at 263.86 ± 1.86 mg gallic acid equivalent per 100 g of extract, placing it in the intermediate phenol range comparable to kiwi and orange. The three quantified anthocyanins—cyanidin-3-glucoside (MW 449 g/mol), malvidin-3-glucoside (MW 493 g/mol), and delphinidin-3-glucoside (MW 479 g/mol)—represent the primary flavonoid subclass, alongside phenolic acids gallic acid, ferulic acid, and chlorogenic acid. Macronutrient and micronutrient composition (protein, fat, carbohydrate, fiber, vitamins, and minerals) of the whole fruit has not been comprehensively published in peer-reviewed sources within the available literature. Bioavailability of anthocyanins from sea grape has not been studied in humans, though the successful microencapsulation of extracts with high solubility (76%) suggests that formulation strategies can improve stability and potentially enhance oral bioavailability of labile phenolic compounds.

Preparation & Dosage

- **Fresh Berries (Traditional/Food Use)**: Consumed directly as a whole fruit in Caribbean and Florida coastal communities; no standardized therapeutic dose established.
- **Leaf Decoction (Traditional Antidiarrheal)**: Leaves are boiled in water in coastal island traditions to produce a tea consumed for diarrhea; typical folk preparations use a small handful of leaves per cup of water, though no clinically validated dose exists.
- **Ethanolic Extract (Research Form)**: Used in in vitro studies at concentrations of 250 µg/mL to demonstrate anti-inflammatory and antioxidant activity; this concentration is a laboratory parameter and does not constitute a human dose recommendation.
- **Spray-Dried Microencapsulated Powder**: An experimental delivery form produced with maltodextrin carrier, yielding particles of 6.28 µm mean size with 76 ± 3.60% solubility and preserved antimutagenic activity; not yet available as a commercial supplement.
- **Submicron Emulsion (Experimental)**: Ultrasound homogenization has been explored to stabilize sea grape extracts for potential functional food or nutraceutical applications; no dose or bioavailability data in humans available.
- **Standardization**: No commercially standardized extract with defined anthocyanin or polyphenol percentages is currently established in the literature.

Synergy & Pairings

Sea grape's anthocyanin and phenolic acid profile suggests potential synergy with other polyphenol-rich ingredients such as grape seed extract or blueberry, where combined flavonoid fractions may provide complementary radical scavenging across both hydrophilic and lipophilic compartments, though this combination has not been tested experimentally for Coccoloba uvifera specifically. The tannin-rich leaves may act synergistically with probiotic preparations in gastrointestinal contexts, where astringent compounds reduce secretion while probiotics restore microbial balance in diarrheal conditions, representing a theoretically rational combination drawn from traditional and functional medicine frameworks. Microencapsulation with maltodextrin has been demonstrated to improve thermal and UV stability of sea grape extract bioactives, suggesting that co-formulation with antioxidant excipients or delivery systems may be necessary to preserve efficacy in supplement formats.

Safety & Interactions

No formal human safety studies, toxicological assessments, or adverse event reporting for Coccoloba uvifera supplementation or leaf preparations have been identified in the published literature, making it impossible to establish evidence-based maximum safe doses or define a comprehensive side effect profile. The berries are widely consumed as food in the Caribbean without reports of systemic toxicity in the ethnobotanical literature, suggesting reasonable tolerability at culinary quantities, but medicinal-dose leaf decoctions have not been evaluated for safety in controlled settings. No drug interaction data exists for sea grape preparations; however, given the presence of polyphenols and tannins that may influence cytochrome P450 enzymes and drug absorption, caution is theoretically warranted in individuals taking anticoagulants, antihypertensives, or medications with narrow therapeutic windows. Pregnant and lactating women should avoid therapeutic doses of leaf preparations given the complete absence of safety data in these populations, though incidental dietary consumption of the fruit is generally considered low risk.